Patients with chronic rhinosinusitis and serum IgE greater than 1,000 ng/mL have a higher prevalence of allergic bronchopulmonary aspergillosis (ABPA) and nonsteroidal anti-inflammatory drugs exacerbated respiratory disease
Pacientes com rinossinusite crônica e IgE sérica superior a 1.000 ng/mL têm alta prevalência de aspergilose broncopulmonar alérgica (ABPA) e doença respiratória exacerbada por anti-infl amatórios
Priscila Novaes Ferraiolo; Nathalia Fernanda da Silva; Marise da Penha Costa Marques; Sergio Duarte Dortas-Junior; Cláudia Maria Valete; Fabiana Chagas da Cruz
References
1. Fokkens WJ, Lund VJ, Hopkins C, Hellings RW, Kern R, Reltsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;29:1-464.
2. Eraso I, Sangiovanni S, Morales EI, Fernández-Trujillo L. Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis. PLoS One. 2021;26;16: e0247871.
3. Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019 Jan;74(1):28-39. doi: 10.1111/all.13599.
4. Chan ELGL, Shah A. Review of current and future therapeutics in ABPA. There Adv Chronic Dis. 2021;12:1-17.
5. Agarwal R, Sehgal IS, Dhooria S, Muthu V, Prasad KT, Bal A, et al. Allergic bronchopulmonary aspergillosis. Indian J Med Res. 2020;151:529-49.
6. Patel G, Greenberger PA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc. 2019;1:421-4.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email